vs
AMERICAN AXLE & MANUFACTURING HOLDINGS INC（AXL）与百利高（PRGO）财务数据对比。点击上方公司名可切换其他公司
AMERICAN AXLE & MANUFACTURING HOLDINGS INC的季度营收约是百利高的1.2倍（$1.4B vs $1.1B），AMERICAN AXLE & MANUFACTURING HOLDINGS INC净利率更高（-5.4% vs -127.8%，领先122.4%），AMERICAN AXLE & MANUFACTURING HOLDINGS INC同比增速更快（0.2% vs -2.5%），百利高自由现金流更多（$148.6M vs $54.7M），过去两年百利高的营收复合增速更高（1.3% vs -7.2%）
美国车桥制造控股有限公司总部位于密歇根州底特律，是一家美国汽车传动轴与动力传动系统零部件及系统制造商，在汽车传动领域拥有成熟的技术与产能，为全球多家车企供应相关核心配件。
百利高（Perrigo）是一家注册于爱尔兰的非处方仿制药生产商，主打自有品牌OTC药品业务。公司70%的净销售额来自美国医疗市场，为优化税务布局将法定总部设在爱尔兰，该地区销售额仅占总营收的0.6%，2013年曾完成美国历史上第六大企业税收倒置交易。
AXL vs PRGO — 直观对比
营收规模更大
AXL
是对方的1.2倍
$1.1B
营收增速更快
AXL
高出2.7%
-2.5%
净利率更高
AXL
高出122.4%
-127.8%
自由现金流更多
PRGO
多$93.9M
$54.7M
两年增速更快
PRGO
近两年复合增速
-7.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.1B |
| 净利润 | $-75.3M | $-1.4B |
| 毛利率 | 10.2% | 32.6% |
| 营业利润率 | -2.4% | -116.0% |
| 净利率 | -5.4% | -127.8% |
| 营收同比 | 0.2% | -2.5% |
| 净利润同比 | -449.6% | -3093.9% |
| 每股收益（稀释后） | $-0.62 | $-10.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXLPRGO
| Q4 25 | $1.4B | $1.1B | ||
| Q3 25 | $1.5B | $1.0B | ||
| Q2 25 | $1.5B | $1.1B | ||
| Q1 25 | $1.4B | $1.0B | ||
| Q4 24 | $1.4B | $1.1B | ||
| Q3 24 | $1.5B | $1.1B | ||
| Q2 24 | $1.6B | $1.1B | ||
| Q1 24 | $1.6B | $1.1B |
净利润AXLPRGO
| Q4 25 | $-75.3M | $-1.4B | ||
| Q3 25 | $9.2M | $7.5M | ||
| Q2 25 | $39.3M | $-8.4M | ||
| Q1 25 | $7.1M | $-6.4M | ||
| Q4 24 | $-13.7M | $-44.4M | ||
| Q3 24 | $10.0M | $-21.0M | ||
| Q2 24 | $18.2M | $-108.4M | ||
| Q1 24 | $20.5M | $2.0M |
毛利率AXLPRGO
| Q4 25 | 10.2% | 32.6% | ||
| Q3 25 | 12.6% | 36.1% | ||
| Q2 25 | 13.1% | 34.4% | ||
| Q1 25 | 12.3% | 37.6% | ||
| Q4 24 | 11.2% | 33.9% | ||
| Q3 24 | 11.4% | 37.2% | ||
| Q2 24 | 13.3% | 37.0% | ||
| Q1 24 | 12.4% | 33.1% |
营业利润率AXLPRGO
| Q4 25 | -2.4% | -116.0% | ||
| Q3 25 | 3.2% | 7.0% | ||
| Q2 25 | 3.6% | 4.3% | ||
| Q1 25 | 3.0% | 4.5% | ||
| Q4 24 | 2.6% | 10.0% | ||
| Q3 24 | 2.8% | 7.4% | ||
| Q2 24 | 5.3% | -2.5% | ||
| Q1 24 | 4.8% | -5.1% |
净利率AXLPRGO
| Q4 25 | -5.4% | -127.8% | ||
| Q3 25 | 0.6% | 0.7% | ||
| Q2 25 | 2.6% | -0.8% | ||
| Q1 25 | 0.5% | -0.6% | ||
| Q4 24 | -1.0% | -3.9% | ||
| Q3 24 | 0.7% | -1.9% | ||
| Q2 24 | 1.1% | -10.2% | ||
| Q1 24 | 1.3% | 0.2% |
每股收益（稀释后）AXLPRGO
| Q4 25 | $-0.62 | $-10.23 | ||
| Q3 25 | $0.07 | $0.05 | ||
| Q2 25 | $0.32 | $-0.06 | ||
| Q1 25 | $0.06 | $-0.05 | ||
| Q4 24 | $-0.11 | $-0.32 | ||
| Q3 24 | $0.08 | $-0.15 | ||
| Q2 24 | $0.15 | $-0.79 | ||
| Q1 24 | $0.17 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $708.9M | — |
| 总债务越低越好 | $4.0B | — |
| 股东权益账面价值 | $640.0M | $2.9B |
| 总资产 | $6.7B | $8.5B |
| 负债/权益比越低杠杆越低 | 6.31× | — |
8季度趋势，按日历期对齐
现金及短期投资AXLPRGO
| Q4 25 | $708.9M | — | ||
| Q3 25 | $714.1M | $432.1M | ||
| Q2 25 | $586.5M | $454.2M | ||
| Q1 25 | $549.2M | $409.9M | ||
| Q4 24 | $552.9M | $558.8M | ||
| Q3 24 | $542.5M | $1.5B | ||
| Q2 24 | $519.9M | $542.8M | ||
| Q1 24 | $469.8M | $658.5M |
总债务AXLPRGO
| Q4 25 | $4.0B | — | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.6B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
股东权益AXLPRGO
| Q4 25 | $640.0M | $2.9B | ||
| Q3 25 | $718.4M | $4.4B | ||
| Q2 25 | $673.0M | $4.5B | ||
| Q1 25 | $596.3M | $4.4B | ||
| Q4 24 | $562.8M | $4.3B | ||
| Q3 24 | $616.3M | $4.6B | ||
| Q2 24 | $609.6M | $4.5B | ||
| Q1 24 | $621.4M | $4.7B |
总资产AXLPRGO
| Q4 25 | $6.7B | $8.5B | ||
| Q3 25 | $5.3B | $10.1B | ||
| Q2 25 | $5.3B | $10.1B | ||
| Q1 25 | $5.1B | $9.8B | ||
| Q4 24 | $5.1B | $9.6B | ||
| Q3 24 | $5.3B | $11.2B | ||
| Q2 24 | $5.3B | $10.4B | ||
| Q1 24 | $5.4B | $10.6B |
负债/权益比AXLPRGO
| Q4 25 | 6.31× | — | ||
| Q3 25 | 3.61× | — | ||
| Q2 25 | 3.86× | — | ||
| Q1 25 | 4.38× | — | ||
| Q4 24 | 4.58× | — | ||
| Q3 24 | 4.28× | — | ||
| Q2 24 | 4.42× | — | ||
| Q1 24 | 4.40× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $120.5M | $175.4M |
| 自由现金流经营现金流 - 资本支出 | $54.7M | $148.6M |
| 自由现金流率自由现金流/营收 | 4.0% | 13.4% |
| 资本支出强度资本支出/营收 | 4.8% | 2.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $155.1M | $145.1M |
8季度趋势，按日历期对齐
经营现金流AXLPRGO
| Q4 25 | $120.5M | $175.4M | ||
| Q3 25 | $143.3M | $51.7M | ||
| Q2 25 | $91.9M | $75.9M | ||
| Q1 25 | $55.9M | $-64.5M | ||
| Q4 24 | $151.2M | $312.6M | ||
| Q3 24 | $143.6M | $42.2M | ||
| Q2 24 | $142.8M | $9.5M | ||
| Q1 24 | $17.8M | $-1.4M |
自由现金流AXLPRGO
| Q4 25 | $54.7M | $148.6M | ||
| Q3 25 | $79.2M | $29.8M | ||
| Q2 25 | $34.6M | $56.7M | ||
| Q1 25 | $-13.4M | $-90.0M | ||
| Q4 24 | $73.2M | $274.9M | ||
| Q3 24 | $70.4M | $15.1M | ||
| Q2 24 | $94.0M | $-18.9M | ||
| Q1 24 | $-30.2M | $-26.5M |
自由现金流率AXLPRGO
| Q4 25 | 4.0% | 13.4% | ||
| Q3 25 | 5.3% | 2.9% | ||
| Q2 25 | 2.3% | 5.4% | ||
| Q1 25 | -0.9% | -8.6% | ||
| Q4 24 | 5.3% | 24.2% | ||
| Q3 24 | 4.7% | 1.4% | ||
| Q2 24 | 5.8% | -1.8% | ||
| Q1 24 | -1.9% | -2.4% |
资本支出强度AXLPRGO
| Q4 25 | 4.8% | 2.4% | ||
| Q3 25 | 4.3% | 2.1% | ||
| Q2 25 | 3.7% | 1.8% | ||
| Q1 25 | 4.9% | 2.4% | ||
| Q4 24 | 5.6% | 3.3% | ||
| Q3 24 | 4.9% | 2.5% | ||
| Q2 24 | 3.0% | 2.7% | ||
| Q1 24 | 3.0% | 2.3% |
现金转化率AXLPRGO
| Q4 25 | — | — | ||
| Q3 25 | 15.58× | 6.89× | ||
| Q2 25 | 2.34× | — | ||
| Q1 25 | 7.87× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 14.36× | — | ||
| Q2 24 | 7.85× | — | ||
| Q1 24 | 0.87× | -0.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXL
| Driveline | $748.4M | 54% |
| Other | $345.7M | 25% |
| Metal Forming | $289.8M | 21% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
